Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $11.1 million.

  • Phibro Animal Health's Capital Expenditures rose 4186.91% to $11.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $45.8 million, marking a year-over-year increase of 1388.53%. This contributed to the annual value of $38.3 million for FY2025, which is 714.15% down from last year.
  • Phibro Animal Health's Capital Expenditures amounted to $11.1 million in Q4 2025, which was up 4186.91% from $13.8 million recorded in Q3 2025.
  • Phibro Animal Health's Capital Expenditures' 5-year high stood at $23.2 million during Q3 2022, with a 5-year trough of $7.1 million in Q2 2021.
  • Over the past 5 years, Phibro Animal Health's median Capital Expenditures value was $9.8 million (recorded in 2022), while the average stood at $10.4 million.
  • As far as peak fluctuations go, Phibro Animal Health's Capital Expenditures soared by 21112.9% in 2022, and later plummeted by 6774.25% in 2023.
  • Over the past 5 years, Phibro Animal Health's Capital Expenditures (Quarter) stood at $7.7 million in 2021, then increased by 27.69% to $9.8 million in 2022, then rose by 11.61% to $11.0 million in 2023, then dropped by 28.62% to $7.8 million in 2024, then skyrocketed by 41.87% to $11.1 million in 2025.
  • Its Capital Expenditures stands at $11.1 million for Q4 2025, versus $13.8 million for Q3 2025 and $13.1 million for Q2 2025.